U.S. Breast Implants Market Size, Share & COVID-19 Impact Analysis, By Product (Breast Implants and Tissue Expanders), By Material (Silicone and Saline), By Procedure (Breast Augmentation and Breast Reconstruction) By End-user (Hospitals and Specialty Clinics), and Country Forecast, 2023-2030

The U.S. breast implants market size was worth USD 1.08 billion in 2022 and is projected to grow at a CAGR of 7.4% during the forecast period.

Breast implants are used either to increase the size of the breast or to reconstruct the breast after injury or cancer. An increasing number of women going for breast augmentation procedures to enhance their physical appearance, rising number of mastectomy procedures, and new advanced breast implant launches have been fueling the market growth.

• For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2021, around 378,700 breast augmentations were conducted in the U.S., experiencing an increase of 1.8% over the previous year.

The COVID-19 pandemic had a negative impact on the market in 2020. This was due to the postponement of implantation surgeries, including breast implantation procedures.

LATEST TRENDS

Emergence of Gummy Bear Implants is the Latest Trend

Demand for gummy bear implants has increased recently as compared to other implants. Due to strong crosslinking ability, these implants provide good shape and do not cause any wrinkles. Such advantages associated with these implants have fueled their demand among the female population. Moreover, these implants are much safer than conventional implants.

The first gummy bear implant was approved by the FDA in 2012. Since then, the demand for these implants has been increasing significantly among the female population. This has been recorded as they look more natural than other implants.

Moreover, under-the-muscle breast enlargement has enhanced the variety of implants available in the market. Under-the-muscle breast augmentation surgeries have recently become popular as the procedures are minimally invasive.

DRIVING FACTORS

Increasing Prevalence of Breast Cancer has been Fueling the Market Growth

Mastectomy is the complete removal of the breast to treat breast cancer. In some cases, only breast tissues are removed, excluding the skin. In such scenarios, breast implantation procedures are conducted. Therefore, the increasing prevalence of breast cancer has been fueling the demand for breast implants.

• For instance, according to data published by the Centers for Disease Control and Prevention (CDC) and reviewed in September 2022, around 264,000 breast cancer cases in women are diagnosed in the U.S. annually.

The increasing demand for breast augmentation due to the rising burden of breast cancer has been fueling the U.S. breast implants market growth.

Request a Free sample to learn more about this report.

In 2021, around 378,700 million breast implantation procedures were conducted in the U.S., experiencing an increase of 17.8% from 2018.

RESTRAINING FACTORS

Complications Associated with the Use of Breast Implants May Restrict the Market Growth

With the rising awareness about breast reconstruction surgery, the demand for breast implant products has increased recently. However, certain risk factors are associated with these implants, such as severe pain in the breast area, infection, salt water leakage from a saline-filled breast implant, and others limit the adoption of the product among the population.

Moreover, regulatory bodies have also implemented certain regulations to create awareness among the population regarding the risk factors associated with breast implantations.

• For instance, in October 2021, the U.S. FDA updated the safety requirement for implants in response to the risk factors associated with using breast implants. In this update, the FDA restricted the sales and distribution of these implants so that patients consider its potential risks. Moreover, they also approved labeling on the marketed implants, including the warning and risk factors associated with using these implants.

The risk factors associated with breast implantation and increasing focus of regulatory bodies on creating awareness about these risk factors may restrict the market growth.

SEGMENTATION

By Product Analysis

Based on product, the U.S. market is classified into breast implants and tissue expanders.

The breast implant segment dominated the market in 2022. The implants help in reconstruction of the breast after the mastectomy. The increasing prevalence of invasive breast cancer and the rising number of mastectomy procedures in the country is responsible for the segment’s dominance.

• For instance, the American Society of Clinical Oncology (ASCO) estimated that around 297,790 women in the U.S. would be diagnosed with invasive cancer.

By Material Analysis

On the basis of material, the U.S. breast implants market is bifurcated into silicone and saline.

The silicone segment dominated the market in 2022. The segment’s dominance in the market is attributed to the various advantages associated with the use of these implants. These include their stability at high temperatures, moisture resistance, resistance to aging, and others.

By Procedure Analysis

On the basis of procedure, the market is bifurcated into breast augmentation and breast reconstruction.

The breast augmentation segment dominated the market in 2022. Strategic collaborations amongst key players for new product development are responsible for the segment’s growth. Moreover, an increase in breast augmentation procedures has also been fueling the segment’s growth.

• For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2021, around 378,700 breast augmentation procedures were conducted, accounting for 52.0% of the total breast surgeries in the U.S.

By End-user Analysis

By end-user, the market is bifurcated into hospitals and specialty clinics.

The hospitals segment dominated the market in 2022. The segment’s growth is attributed to patients' preference for hospitals to conduct surgical procedures. Moreover, the increasing number of mastectomy procedures in the country has increased the demand for these implants, fueling the segment’s growth.

KEY INDUSTRY PLAYERS

Key players in the market, such as GC Aesthetics and Abbvie, Inc., accounted for a significant U.S. breast implants market share in 2022. The strong position of these companies in the market is due to their emphasis on adopting advanced technologies for conducting breast implantation procedures with higher efficiency.

• For instance, in August 2020, GC Aesthetics announced the launch of a breast delivery device to insert silicone implants easily with minimal touch.

Other players in the market, such as Sebbin, Sientra, Inc., and ARION LABORATORIES, have increased their focus on mergers and collaborations to enhance their offerings.

• For instance, in April 2021, Sientra, Inc. partnered with Butterfly Network, Inc., a medical device company, to improve the monitoring of breast implant patients.

LIST OF KEY COMPANIES PROFILED:

• AbbVie Inc. (U.S.)


• GC Aesthetics (Ireland)


• Sebbin (France)


• ARION LABORATORIES (France)


• Johnson & Johnson Services, Inc. (U.S.)


• Sientra, Inc. (U.S.)


• HansBioMed (Korea)

KEY INDUSTRY DEVELOPMENTS:

• January 2022 – Johnson & Johnson Services, Inc., through its subsidiary Mentor Worldwide LLC, announced the U.S. FDA approval of MemoryGel BOOST, a breast implant for breast augmentation.


• October 2021 – Abbvie Inc. launched a breast cancer campaign to increase public awareness regarding breast reconstruction options.


• May 2021 – GC Aesthetics expanded its breast implant portfolio with the launch of PERLE, a next-generation breast implant.

REPORT COVERAGE

An Infographic Representation of U.S. Breast Implants Market

View Full Infographic

To get information on various segments, share your queries with us

The market report provides a detailed analysis of the market. It focuses on key aspects such as an overview of technological advancements, the prevalence of breast cancer in the U.S., and pricing analysis. In addition, it includes an overview of the reimbursement scenario for the devices, new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. Besides this, the report offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation